Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2021

View Archived Issues

Homozygous stop-gain variant in SENP7 gene tied to congenital neutropenia

Researchers develop Phkg2-knockout mouse model of glycogen storage disease type 9

GLS-1027 studied in phase II to prevent severe pneumonitis caused by SARS-CoV-2

RAC1 gene mutations linked to prognosis in head and neck squamous cell carcinoma

GSK stops INDUCE-3 and INDUCE-4 studies evaluating feladilimab plus pembrolizumab

Phase III study of ciclesonide inhaler in COVID-19 does not meet statistical significance

First volunteer dosed in phase I study of COVID-19 candidate HLX-71

FDA lifts partial clinical hold on phase I study of SBP-101 in pancreatic cancer

INO-4800 provides broad cross-reactive immune responses against variant strains of SARS-CoV-2

Merck & Co. discontinues development of MK-7110 for COVID-19

First patient enrolled in phase I/II clinical program for QLS-101

Medshine Discovery patents CRAC blockers

Novartis divulges new EED and/or EZH2 inhibitors

Betta Pharmaceuticals identifies EGFR inhibitors

Nanjing TransThera Biosciences presents TAM family kinase inhibitors

New conjugated chimeric proteins presented by Orionis Biosciences

JNJ-74856665 mediates potent antileukemic activity and differentiation in preclinical models

Icatibant portion of I-SPY COVID trial ends after futility criterion met

Praxis initiates phase II/III trial of PRAX-114 for major depressive disorder

Enrollment opens in phase Ib study of RO-7122290 with cibisatamab in colorectal cancer

Discovery of allosteric MALT1 protease inhibitor JNJ-67856633 for cancer

Yale begins phase I study of BMS-984923 for Alzheimer's disease

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

Aussie researchers show critical role of DC-SCRIPT in producing key dendritic immune cells

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...